Quantcast
Home > Quotes > GILD
GILD

Gilead Sciences, Inc. Common Stock (GILD) Quote & Summary Data

$66.89
*  
0.28
0.42%
Get GILD Alerts
*Delayed - data as of May 24, 2019  -  Find a broker to begin trading GILD now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
83.5
Today's High / Low
$ 67.475 / $ 66.4529
Share Volume
4,197,916
50 Day Avg. Daily Volume
6,927,221
Previous Close
$ 67.17
52 Week High / Low
$ 79.61 / $ 60.32
Market Cap
85,277,793,440
P/E Ratio
14.77
Forward P/E (1y)
10.13
Earnings Per Share (EPS)
$ 4.53
Annualized Dividend
$ 2.52
Ex Dividend Date
6/13/2019
Dividend Payment Date
6/27/2019
Current Yield
3.77 %
Beta
1.05

Intraday Chart

Shares Traded

Share Volume:
4,197,916
50 Day Avg. Daily Volume:
6,927,221

P/E Ratio

P/E Ratio:
14.77
Forward P/E (1y):
10.13
Earnings Per Share (EPS):
$ 4.53

Trading Range

The current last sale of $66.89 is 10.89% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 67.475 $ 79.61
 Low: $ 66.4529 $ 60.32

ETFs with GILD as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
8.94% iShares Nasdaq Biotechnology Index Fund (IBB) +7.77 (8.06%)
7.06% VanEck Vectors Biotech ETF (BBH) +9.78 (8.83%)
3.7% First Trust Amex Biotech Index Fund (FBT) +8.29 (6.67%)
3.53% iShares MSCI Global Impact ETF (SDG) +3.47 (6.55%)
2.79% ValueShares U.S. Quantitative Value ETF (QVAL) +1.96 (7.85%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Gilead Sciences, Inc. (Gilead, we, our or us), incorporated in Delaware on June 22, 1987, is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we strive to transform and simplify care for people with life-threatening illnesses around the world. We have operations in more than 35 countries worldwide, with headquarters in Foster City, California. Gilead's primary areas of focus include HIV/AIDS, liver diseases, hematology/oncology and inflammation/respiratory diseases. We seek to add to our existing portfolio of products through our internal discovery and clinical development programs, product acquisition, in-licensing and strategic collaborations. 2018 Highlights 2018 was marked by operational excellence and transition as we positioned ourselves for the future growth of our business.  ... More ...  



Risk Grade

Where does GILD fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 67.30
Open Date:
May 24, 2019
Close Price:
$ 66.89
Close Date:
May 24, 2019


Consensus Recommendation

Analyst Info